batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Merck and Daiichi look for more ifinatamab white space 22 April 2025 First-line breast cancer is in Enhertu’s Destiny 22 April 2025 HengRui challenges with a Polivy follow-on 22 April 2025 Another pivotal-stage EGFR conjugate 17 April 2025 Ivonescimab goes post-checkpoint 16 April 2025 J&J has a long Rybrevant road ahead 15 April 2025 A tale of two markets for Chinese groups 15 April 2025 Bristol scores in liver; next up, TIGIT 14 April 2025 Load More